Results 11 to 20 of about 7,562 (197)

Association of Bullous Lichen Sclerosus and Morphea [PDF]

open access: yesClinical Case Reports
Lichen sclerosus (LSc) is an inflammatory skin disease of unknown etiology. The coexistence of LSc and morphea in the same lesion is uncommon but exists. Also, there exist a few rare cases of bullous LSc–generalized morphea overlap syndrome.
Seyyede Zeinab Azimi   +3 more
doaj   +3 more sources

Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives [PDF]

open access: yesJournal of Mind and Medical Sciences, 2020
Morphea or localized scleroderma is an uncommon autoimmune and inflammatory disease which affects patients of any age. Even if morphea lesions present systemic symptoms as myalgias or arthritis, it is distinct from systemic sclerosis because it does not ...
Alin Laurentiu Tatu   +4 more
doaj   +2 more sources

Clinical Images: Unilateral skin induration and pigmentation: a case of generalized morphea [PDF]

open access: yesACR Open Rheumatol
ACR Open Rheumatology, Volume 7, Issue 6, June 2025.
Wan‐Hao Tsai, Ko‐Jen Li
wiley   +2 more sources

Upadacinib for the Treatment of Refractory Morphea [PDF]

open access: yesAustralas J Dermatol
Australasian Journal of Dermatology, Volume 66, Issue 4, Page 238-239, June 2025.
Vincenzo Maione   +5 more
wiley   +2 more sources

Is adiponectin involved in morphea pathogenesis? – first observational study [PDF]

open access: yesFrontiers in Immunology
BackgroundMorphea is a chronic inflammatory condition characterized by fibrosis of the skin and/or subcutaneous tissues. Adiponectin is an adipokine known for its anti-inflammatory and antifibrotic properties.
Adriana Polańska   +5 more
doaj   +2 more sources

High‐Frequency Ultrasound Assessment of Skin Thickness Following Lipofilling in Facial Sclerosing Dermatoses: A Case Series [PDF]

open access: yesJ Cosmet Dermatol
Journal of Cosmetic Dermatology, Volume 24, Issue 5, May 2025.
Sofia Gomez‐Martinez   +12 more
wiley   +2 more sources

Profiling of Toll-like Receptors and Related Signaling Mediators in the Pathogenesis of Morphea [PDF]

open access: yesDermatology Practical & Conceptual
Introduction: Morphea, also known as localized scleroderma, is a rare fibrosing inflammatory disease of unknown pathogenesis. Objectives: Although the genetic basis for morphea is important, the evaluation of Toll-like receptors (TLR) in this disease ...
Hilal Ayvaz Celik   +4 more
doaj   +2 more sources

A Patient With Plaque Type Morphea Mimicking Systemic Lupus Erythematosus [PDF]

open access: yesActa Medica Indonesiana, 2015
Morphea is an uncommon connective tissue disease with the most prominent feature being thickening or fibrosis of the dermal without internal organ involvement. It is also known as a part of localized scleroderma.
Wardhana Wardhana, EA Datau
doaj   +3 more sources

Enhancing Hair Regrowth in Pediatric Morphea en Coup de Sabre by Fractional CO2 Laser‐Assisted Exosome Delivery [PDF]

open access: yesJ Cosmet Dermatol
Journal of Cosmetic Dermatology, Volume 24, Issue 6, June 2025.
Rhea Ahuja, Patrick Po‐Han Huang
wiley   +2 more sources

Generalized morphea following radiotherapy for an intracranial tumor

open access: diamondIndian Journal of Dermatology, 2016
Morphea is a localized scleroderma variety which can be circumscribed or generalized and is characterized by sclerotic plaques developing on trunk and limbs. Surgery and radiation have been implicated as etiological factors for the development of morphea.
Shrenik Balegar   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy